This is a firm fixed-price delivery order contract awarded by the Defense agency Medical Supply Chain to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of the antiviral medication zanamivir for inhalation. The contract has a ceiling value of $248,859.99 and a period of performance through December 15, 2016. The contract was not set aside for a specific business type. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antivirals, and other pharmaceutical products to U.S. government agencies, including the Departments of Defense, Veterans Affairs, Health and Human Services, and others, through federal contracts and grants. This contract supports the government's disease prevention and treatment efforts.